Showing results (121-130 of 286) with videos related to
Sort By:
Pageof 29
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
Antiangiogenic therapies for malignant pleural mesotheliomaSeiji Yano, Qi Li, Wei Wang, et al.Molecular Cancer Therapeutics|October 29, 2017
Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring <i>RAS</i> MutationsTadaaki Yamada, Joseph M Amann, Azusa Tanimoto, et al.Oncology Research|February 14, 2007
Restored expression of the MYO18B gene suppresses orthotopic growth and the production of bloody pleural effusion by human malignant pleural mesothelioma cells in SCID miceNobutaka Edakuni, Kenji Ikuta, Seiji Yano, et al.International Journal of Cancer|September 18, 2015
Organ-specific efficacy of HSP90 inhibitor in multiple-organ metastasis model of chemorefractory small cell lung cancerShinji Takeuchi, Koji Fukuda, Sachiko Arai, et al.Cancer Science|August 30, 2008
Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1 and LPA2Tadaaki Yamada, Seiji Yano, Hirokazu Ogino, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 18, 2012
Hsp90 inhibition overcomes HGF-triggering resistance to EGFR-TKIs in EGFR-mutant lung cancer by decreasing client protein expression and angiogenesisHitomi Koizumi, Tadaaki Yamada, Shinji Takeuchi, et al.Molecular Cancer|November 22, 2019
EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expressionShunli Peng, Rong Wang, Xiaojuan Zhang, et al.Oncology Reports|May 11, 2006
Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancerSeiji Yano, Hideyasu Matsuyama, Hiroshi Hirata, et al.Journal of Pharmacological Sciences|June 7, 2005
A novel Src kinase inhibitor, M475271, inhibits VEGF-induced human umbilical vein endothelial cell proliferation and migrationNermin Ali, Masanori Yoshizumi, Yoshiko Fujita, et al.Biochemistry and Biophysics Reports|April 28, 2025
HDAC5, an early osimertinib-responsive gene, is a novel therapeutic target for the drug resistance in <i>EGFR</i>-mutant lung adenocarcinoma cellsHanbing Lyu, Akihiko Ishimura, Ryusuke Suzuki, et al.Pageof 29